...Molecular target: fabI enoyl-(acyl carrier protein) reductase Description: Oral formulation of a small molecule prodrug inhibitor of the bacterial fabI enoyl-(acyl carrier protein) reductase...
...after 7-14 days of treatment Status: Phase II data Milestone: NA Jaime De Leon oral Debio 1450 Debiopharm Group fabI enoyl-(acyl carrier protein) reductase...

...Molecular target: fabI enoyl-(acyl carrier protein) reductase Description: IV formulation of a small molecule prodrug inhibitor of the bacterial fabI enoyl-(acyl carrier protein) reductase...
...after 7-14 days of treatment Status: Phase II data Milestone: NA Jaime De Leon IV Debio 1450 Debiopharm Group fabI enoyl-(acyl carrier protein) reductase...

...with FDA's 2013 final guidance (see BioCentury Extra, Oct. 17, 2013) . Jaime De Leon Debio 1450 Debiopharm Group fabI enoyl-(acyl carrier protein) reductase...

...kidneys. The company’s most advanced clinical program is CG400549 , a potentially first-in-class antibiotic targeting fabI enoyl-(acyl carrier protein) reductase...

...skin structure infections and to treat vancomycin-resistant Staphylococcus aureus infections. CG400549 is an antibiotic targeting fabI enoyl-(acyl carrier protein) reductase...

...Gram-negative bacteria, filed for bankruptcy in June. Debiopharm Group is developing Debio 1452 , a fabI enoyl-(acyl carrier protein) reductase...

...AFN-1720 ) Business: Infectious Molecular target: fabI enoyl-(acyl carrier protein) reductase Description: Small molecule prodrug inhibitor of the bacterial fabI enoyl-(acyl carrier protein) reductase...

...Molecular target: fabI enoyl-(acyl carrier protein) reductase Description: Oral formulation of a small molecule prodrug inhibitor of the bacterial fabI enoyl-(acyl carrier protein) reductase...

...bacterial skin and skin structure infections (ABSSSI). The small molecule prodrug inhibitor of the bacterial fabI enoyl-(acyl carrier protein) reductase...

...Molecular target: fabI enoyl-(acyl carrier protein) reductase Description: Oral formulation of a small molecule prodrug inhibitor of the bacterial fabI enoyl-(acyl carrier protein) reductase...